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Roles of lipooligosaccharide and capsular polysaccharide in antimicrobial
resistance and natural transformation of Campylobacter jejuni
Abstract
Objectives
This study is aimed to determine the role of capsular polysaccharide (CPS) and lipooligosaccharide (LOS) in
modulating antimicrobial resistance and natural transformation of Campylobacter jejuni, an important food-
borne human pathogen.
Methods
A series of C. jejuni mutants, which are defective in either CPS or LOS or both, were constructed. The
antimicrobial susceptibility, bacterial surface hydrophobicity, natural transformation frequency and DNA
binding and uptake were measured and compared between the mutants and the wild-type strain.
Results
Truncation of LOS greatly reduced (8-fold) the intrinsic resistance of C. jejuni to erythromycin, a key
antibiotic used for treating human campylobacteriosis, while the loss of CPS did not result in significant
changes in the susceptibility to antimicrobial agents. Notably, mutation of LOS also significantly increased
(>16-fold) the susceptibility to erythromycin in C. jejuni mutants carrying the A2074G mutation in 23S
rRNA. The increased susceptibility to erythromycin in the LOS mutant was probably due to enhanced
permeability to this antibiotic, because the LOS mutation rendered the surface of C. jejuni more hydrophobic.
Loss of CPS and truncation of LOS increased the transformation frequency by 4- and 25-fold, respectively,
and mutation of both CPS and LOS resulted in a 97-fold increase in the transformation frequency. Consistent
with the increased transformation frequencies, the CPS and LOS mutants showed enhanced rates of DNA
uptake.
Conclusions
These results demonstrate that the surface polysaccharides in C. jejuni contribute to the resistance to
erythromycin, a clinically important antibiotic, but restrict natural transformation.
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Objectives: This study is aimed to determine the role of capsular polysaccharide (CPS) and lipooligo-
saccharide (LOS) in modulating antimicrobial resistance and natural transformation of Campylobacter
jejuni, an important food-borne human pathogen.
Methods: A series of C. jejuni mutants, which are defective in either CPS or LOS or both, were con-
structed. The antimicrobial susceptibility, bacterial surface hydrophobicity, natural transformation
frequency and DNA binding and uptake were measured and compared between the mutants and the
wild-type strain.
Results: Truncation of LOS greatly reduced (8-fold) the intrinsic resistance of C. jejuni to erythromycin,
a key antibiotic used for treating human campylobacteriosis, while the loss of CPS did not result in
significant changes in the susceptibility to antimicrobial agents. Notably, mutation of LOS also signifi-
cantly increased (>16-fold) the susceptibility to erythromycin in C. jejuni mutants carrying the A2074G
mutation in 23S rRNA. The increased susceptibility to erythromycin in the LOS mutant was probably
due to enhanced permeability to this antibiotic, because the LOS mutation rendered the surface of
C. jejuni more hydrophobic. Loss of CPS and truncation of LOS increased the transformation fre-
quency by 4- and 25-fold, respectively, and mutation of both CPS and LOS resulted in a 97-fold
increase in the transformation frequency. Consistent with the increased transformation frequencies,
the CPS and LOS mutants showed enhanced rates of DNA uptake.
Conclusions: These results demonstrate that the surface polysaccharides in C. jejuni contribute to the
resistance to erythromycin, a clinically important antibiotic, but restrict natural transformation.
Keywords: food safety, macrolides, competence, drug susceptibility
Introduction
Gram-negative bacteria possess surface polysaccharides such as
capsular polysaccharide (CPS) and lipopolysaccharide (LPS) on
the outer membrane. These surface polysaccharides are attached
to bacterial cells by covalent linkages to their lipid moieties.1,2
Since the surface polysaccharides constitute the outermost layer
of the Gram-negative bacterial cell, they directly interact with
the surrounding environments, providing a permeability barrier
to noxious antimicrobial agents and conferring resistance to host
immunity.1,3 The LPS structure embedded in the outer leaflet of
the outer membrane considerably decreases the permeability of
hydrophobic compounds through the outer membrane and con-
tributes to the general resistance of Gram-negative bacteria to
hydrophobic antibiotics such as macrolides.1,4
Campylobacter jejuni is a Gram-negative bacterium and a
major food-borne pathogen frequently associated with human
gastroenteritis worldwide.5 More than 2 million cases of
Campylobacter infections occur in the USA each year.6
Campylobacter infection is characterized by diarrhoea, fever and
abdominal cramps and occasionally causes Guillain–Barre´ syn-
drome as a post-infection complication.7 When clinical treatments
are warranted, macrolides and fluoroquinolones are the drugs of
choice to treat Campylobacter infections.7 However, the resistance
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of Campylobacter to both classes of antibiotics has been on the
rise and is considered a threat to public health.8 Several general
mechanisms involved in bacterial resistance to antibiotics have
been described, including antibiotic inactivation, target modifi-
cation, active efflux and reduced cell permeability.9 The first three
general mechanisms have been well studied in Campylobacter,10
but the influence of cell surface structures on the susceptibility to
clinically important antibiotics by altering cell permeability is still
poorly understood in this bacterium.
One of the unique features of C. jejuni is its ability to take up
DNA by natural transformation.11 Our recent work showed that
natural transformation plays an important role in horizontal trans-
fer of antibiotic resistance determinants in Campylobacter.12 As a
first step during the process of natural transformation in
Gram-negative bacteria including C. jejuni, free DNA in the
environment must interact with the surface polysaccharide layer
prior to contacting the competence proteins in the cell membrane.
Thus, it is conceivable that alteration of the surface polysaccharide
structures would affect the efficiency of natural transformation.
C. jejuni possesses both CPS and lipooligosaccharide (LOS).13
The LOS differs from LPS in that LOS does not possess an
O-antigen polysaccharide chain.13 These surface polysaccharide
structures are highly variable among different Campylobacter
strains14,15 and are related to the virulence of this bacterium.16,17
Molecular mimicry between C. jejuni LOS and human ganglio-
sides is also implicated in Guillain–Barre´ syndrome, a paralytic
neuropathy.13 Despite the advances in understanding the structures
and functions of CPS and LOS, their roles in the natural trans-
formation and antibiotic resistance in Campylobacter remain to be
determined. In a previous study, Kanipes et al.16 demonstrated
that C. jejuni LOS is associated with resistance to fusidic acid,
novobiocin and SDS, but its contribution to clinically important
antibiotics, such as fluoroquinolones and macrolides, was not
determined in that work. In this study, we demonstrated that LOS,
but not CPS, plays an important role in Campylobacter resistance
to erythromycin and that surface polysaccharides restrict the
natural transformation frequency of C. jejuni NCTC 11168.
Materials and methods
Bacterial strains and culturing conditions
C. jejuni NCTC 11168 and its derivatives were used in this study.
C. jejuni strains JL271, JL272 and JL273 are highly resistant to
erythromycin (MIC .512 mg/L), carry the A2074G mutation in
23S rRNA and were derived from chickens fed with tylosin in a pre-
vious study.18 JB304 is a derivative of strain 11168, which was con-
structed in this study by transformation with the genomic DNA of
strain JL271 and is highly resistant to erythromycin. The strains
were grown in Mueller–Hinton (MH) medium under microaerobic
(5% O2/10% CO2/85% N2) conditions at 428C. When needed, the
culture medium was supplemented with kanamycin (50 mg/L), tetra-
cycline (5 mg/L) or chloramphenicol (10 mg/L).
Construction of CPS and LOS mutants
To construct a CPS mutant, a 1693 bp region harbouring kpsS was
PCR-amplified with kpsS_F and kpsS_R primers (Table 1) and
cloned into pGEM-T (Promega, Madison, WI, USA) to yield
pGEM-T::kpsS. The pGEM-T::kpsS plasmid was digested with SwaI
and ligated with the aphA3 gene, which was amplified from
pMW1019 with Kan_F and Kan_R (Table 1). The suicide vector
was introduced to C. jejuni 11168 by electroporation, and the result-
ing mutants were selected on MH agar plates containing kanamycin
(50 mg/L). The mutation in kpsS was confirmed by PCR (data not
shown) and the mutant was named JB301. For constructing an LOS
mutant, a 2206 bp region containing waaF was amplified with
Ex TaqTM (TaKaRa Bio Inc., Japan) using primers waaF_F and
waaF_R (Table 1) and cloned into pGEM-T to yield
pGEM-T::waaF. Digestion of pGEM-T::waaF with BglII removed a
649 bp internal fragment of waaF, and the construct was
blunt-ended by treatment with Klenow fragment (TaKaRa Bio Inc.).
The tetracycline resistance cassette (tetO) was amplified with VentR
w
DNA polymerase (New England Biolab, Ipswich, MA, USA) from
pTet in C. jejuni 81-176,20 using TetOF and TetOR primers
(Table 1). The tetO gene was inserted into the waaF on
pGEM-T::waaF, and the construct was electroporated into C. jejuni
11168. The resulting transformants were selected by growth on MH
agar plates containing tetracycline (5 mg/L). The waaF mutant was
confirmed by PCR (data not shown) and was named JB302. The
double mutant JB303, which carries mutations in both kpsS and
waaF, was constructed by transforming JB301 with the genomic
DNA of JB302. The double mutant was selected by growth on MH
agar plates containing both tetracycline (5 mg/L) and kanamycin
(50 mg/L).
waaF and kpsS mutants were also constructed with
macrolide-resistant C. jejuni strains (JB304, JL271, JL272 and
JL273). The kpsS and waaF mutants of these strains were con-
structed by transforming these strains using the genomic DNA of
JB301 (kpsS::aphA3) and JB302 (waaF::tetO), respectively, and the
Table 1. PCR primers used in this study
Primers Sequence (50 to 30)
kpsS_F GCT CAA GTT GAA GAT GAT GCT TCG ATG AT
kpsS_R CAT ACC AAA ACA GGA TTG GGT TTA TAA GCA TGA
Kan_F CTTATCAATATATCCATGGAATGGGCAAAGCAT
Kan_R GATAGAACCATGGATAATGCTAAGACAATCACTAAA
waaF_F CCA AAC CGA CCA GCA AAA ATG CCT TTG T
waaF_R GAT GAA GAC ACG CCT TTA GAA CTT ATA AGC TT
TetOF TTA TTT TTG CAT AAA CAG ATG ATT AGT G
TetOR GCA AGC TGT TAA GCT AAC TTG T
waaF_comF CCC AAA TTT CTA CTT GCA AAA GTG CCC AAA
waaF_comR GGT ATT TCA ACG AGC GGA AAA AGC CCT AAT
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transformants were selected by growth on MH agar plates contain-
ing kanamycin (50 mg/L) or tetracycline (5 mg/L). The insertional
mutations in kpsS and waaF of these erythromycin-resistant strains
were confirmed by PCR (data not shown).
Detection of LOS and CPS by Alcian Blue staining
CPS and LOS preparation and Alcian Blue staining were performed
according to the previously reported method.21 Briefly, a loopful of
1-day-old C. jejuni culture grown on MH agar plates was resus-
pended in lysis buffer containing 62.5 mM Tris–HCl, pH 6.8, 2%
SDS, 10% glycerol and 0.05% Bromophenol Blue. Samples were
boiled for 10 min and centrifuged at 13000 rpm for 5 min. Aliquots
of the supernatant were taken and mixed with proteinase K (Sigma,
St Louis, MO, USA) to a final concentration of 1 mg/mL. The
samples were incubated at 50ºC for 1 h and then fractionated by
SDS–PAGE. LOS and CPS were visualized with Alcian Blue stain-
ing (0.1% Alcian Blue dissolved in 40% ethanol/5% acetic acid).
Complementation of the waaF mutant in trans
Construction of the complementing plasmid for the waaF mutant
was based on a previously published study.16 A 1450 bp region con-
taining waaF and its upstream intergenic region was amplified with
VentR
w DNA polymerase, using waaF_comF and waaF_comR
primers (Table 1). The PCR product was cloned into the SmaI site
of pRY112. The constructed plasmid was introduced into the waaF
mutant of C. jejuni strains 11168 (JB302), JL271 and JL273 by con-
jugation, as described previously.22 The waaF-complemented strain
JB302 was named JB302C.
Susceptibility tests
The MICs of various antibiotics, SDS and choleate were determined
with a microtitre broth dilution method as described previously.23
Antimicrobial agents were purchased from Sigma (erythromycin,
cefotaxime, gentamicin, rifampicin, polymyxin B, streptomycin,
SDS and choleate) and MP Biomedicals, Irvine, CA, USA
(ciprofloxacin).
Hydrophobicity assay
Hydrophobicity of C. jejuni strains was measured by a salting-out
method as described by Misawa and Blaser.24 Briefly, overnight cul-
tures of C. jejuni strains were resuspended in 2 mM sodium phos-
phate (Sigma) to an optical density at 600 nm (OD600) of 1.0.
Ammonium sulphate (4 M) was dissolved in 2 mM sodium phos-
phate and 2-fold serially diluted in U-bottomed 96-well plates. An
equal volume (25 mL) of bacterial suspension was added to each
well containing ammonium sulphate. The plates were incubated at
room temperature overnight. The minimum concentration of
ammonium sulphate forming bacterial aggregation was determined
and used for the hydrophobicity index. Hydrophobicity is inversely
correlated with the concentration of ammonium sulphate causing
bacterial aggregation.
Natural transformation
Natural transformation was performed as described previously11
with some modifications. C. jejuni cultures grown overnight on MH
agar plates were collected and resuspended in MH broth to OD600
of 0.05. Bacterial suspensions (0.5 mL) were transferred to sterilized
tubes, incubated at 378C with shaking (200 rpm) under microaerobic
conditions for 3 h and then 1 mg of genomic DNA of JB201 or
JB202,12 which carry the chloramphenicol resistance gene (cat) and
the kanamycin resistance gene (aphA3), respectively, was added to
each tube. After additional incubation for 4 h, bacterial cultures
were serially diluted and plated on MH agar plates with or without
antibiotics (10 mg/L chloramphenicol or 50 mg/L kanamycin) to
count the numbers of transformants and the total bacterial number,
respectively. Transformation frequency was calculated by dividing
the number of transformants from 1 mg of donor DNA by the total
number of bacteria.
DNA binding and uptake assay
Genomic DNA from C. jejuni NCTC 11168 was extracted using the
Wizard Genomic DNA Purification Kit (Promega). Up to 400 ng of
chromosomal DNA was nick translated using the Nick Translation
Kit (Roche, Indianapolis, IN, USA) in the presence of 100 mCi of
[a-32P]dCTP (Perkin Elmer, Waltham, MA, USA) as recommended
by the manufacturer. Unincorporated nucleotides were removed by
ethanol precipitation and the DNA was resuspended in 82 mL of
double distilled water. The CPS and LOS mutants and the wild-type
11168, grown for 18 h on MH agar, were resuspended in 10 mL
MH broth to an OD600 of 0.1. The culture tubes were incubated
microaerobically with shaking (250 rpm) until the optical density
had doubled (3 h). Cells were harvested by centrifugation at
4000 g for 20 min and resuspended in 3.3 mL MH broth. Each
culture was adjusted to the same optical density at OD600 to ensure
an equivalent number of cells were used in the DNA binding and
uptake assay for each strain. To each culture (1 mL), 100 ng of
32P-labelled DNA was added, and the culture was incubated micro-
aerobically with labelled DNA for 2 h and divided into two 500 mL
aliquots. DNaseI was added to the aliquots for DNA uptake assay to
a final concentration of 100 mg/L to digest extracellular DNA. After
DNase I treatment for 10 min at room temperature, cells were
washed three times with MH broth and resuspended in 100 mL of
ice-cold water prior to liquid scintillation (Beckman Coulter). Since
the intracellular DNA is protected from DNaseI treatment, the
amount of radioactivity from the samples treated with DNaseI rep-
resents the level of DNA uptake. The radioactivity of the sample
without DNaseI treatment was considered the DNA-binding level.
Three independent experiments were performed.
Statistical analysis
Normality and variance of each dataset were assessed by
D’Agostino Omnibus25 and Modified-Levene test,26 respectively.
Differences between the wild-type and each mutant strain in hydro-
phobicity were tested using the Mann–Whitney U-test, and the
Student t-test was used for the transformation frequency dataset. For
the analysis of the results of DNA binding and uptake, ANOVA was
used with the strain and DNaseI treatment as fixed variables, and
the Bonferroni corrected multiple comparison t-test was applied to
variables with significant main or interaction effects.
Results
Contribution of LOS, but not CPS, to the intrinsic
resistance to erythromycin
Multiple genes clustered in two separate loci are involved in LOS
and CPS biosynthesis in C. jejuni. Based on their importance in
LOS and CPS production,27,28 we selected waaF and kpsS as
Jeon et al.
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target genes to disrupt LOS and CPS, respectively. The waaF
gene encodes a heptosyltransferase, while kpsS encodes a puta-
tive CPS transporter. Truncation of LOS and loss of CPS in these
mutants were confirmed by Alcian Blue staining [Figure S1,
available as Supplementary data at JAC Online (http://jac.oxford-
journals.org/)]. The LOS-complemented strain (JB302C) par-
tially restored the production of intact LOS (Figure S1a). Thus,
both the truncated form and the intact form of LOS were seen in
JB302C. The growth rate of the CPS and LOS mutants in MH
broth was comparable to that of the wild-type (data not shown).
The antimicrobial susceptibilities of the CPS and LOS
mutants were compared with that of the wild-type. As shown in
Table 2, the mutations had different effects on the sensitivity to
various antibiotics. Although JB301 (the CPS mutant) and
JB302 (the LOS mutant) did not exhibit any changes in the sus-
ceptibility to ciprofloxacin (a hydrophilic fluoroquinolone),
JB302 showed a significant increase (8-fold) in the susceptibility
to erythromycin. JB302C (JB302 complemented with a plasmid-
carried copy of waaF) had MIC levels similar to those of the
wild-type (Table 2). The LOS mutation also moderately (2-fold)
increased the susceptibility of Campylobacter to polymyxin B
and SDS. These changes were reproducible in four independent
experiments. In contrast to LOS, the mutation of CPS did not
result in an increase in the susceptibilities of the tested anti-
microbials except a minor change (2-fold) in SDS. Instead, the
CPS mutant showed slightly decreased sensitivity to some
hydrophilic antibiotics, such as cefotaxime, gentamicin, poly-
myxin B and streptomycin. Compared with JB302, the MICs of
erythromycin, cefotaxime and SDS were further reduced in
JB303 (a CPS and LOS double mutant), but the reduction was
modest (Table 2), suggesting that the MIC changes in the
double mutant were mainly due to the LOS mutation.
Effect of the LOS mutation on the susceptibility to
erythromycin in macrolide-resistant mutants
High-level macrolide resistance in Campylobacter is often
associated with point mutations in the 23S rRNA.29 To
investigate if LOS affects the resistance to macrolide antibiotics
in C. jejuni strains harbouring the A2074G mutation in 23S
rRNA, we introduced the LOS and CPS mutations to JB304,
JL271, JL272 and JL273, which are highly resistant to erythro-
mycin (MIC .512 mg/L). While the CPS mutation did not have
a measurable effect on macrolide resistance in these C. jejuni
strains, the LOS mutation decreased the MIC of erythromycin
from .512 to 16–32 mg/L (a .16-fold reduction). In trans
complementation of the LOS mutants of JL271 and JL273
restored the high-level resistance to erythromycin
(MIC .512 mg/L).
Increased hydrophobicity in CPS and LOS mutants
We hypothesized that the loss of hydrophilic surface polysac-
charides in the CPS and LOS mutants would make the bacterial
surface more hydrophobic than that of the wild-type. To test this
hypothesis, we measured the hydrophobicity of the strains by the
salting-out method. In this assay, a higher concentration of
ammonium sulphate mediating bacterial aggregation indicates
lower hydrophobicity.24 Thus, the concentration of ammonium
sulphate is inversely proportional to hydrophobicity. CPS
mutation was previously reported to increase the hydrophobicity
of C. jejuni.30 In our study, we confirmed the previous finding
regarding the C. jejuni CPS mutant and further demonstrated
LOS had a much greater impact on surface hydrophobicity than
CPS. Mutation of CPS and LOS increased the hydrophobicity by
3.2- and 93-fold, respectively, as reflected by the changes in the
concentration of ammonium sulphate (Figure 1). The CPS and
LOS double mutation resulted in a 171-fold increase in the
hydrophobicity (Figure 1). The differences between the wild-
type and each mutant were statistically significant (P,0.001)
by the Mann–Whitney U-test. These results demonstrated that
CPS and LOS are strongly associated with the surface hydropho-
bicity of C. jejuni.
Contribution of CPS and LOS to natural transformation
We performed natural transformation with these mutants and
found that the CPS and LOS mutations increased the frequency
Table 2. Antimicrobial susceptibility of C. jejuni 11168 and its
derivatives
Antimicrobials
MIC (mg/L)a
11168 JB301 JB302 JB303 JB302C
Ciprofloxacin 0.5 0.5 0.5 0.5 0.5
Erythromycin 0.5 0.5 0.0625 (8) 0.0313 (16) 0.25
Cefotaxime 1 2 (0.5) 1 0.5 (2) 1
Gentamicin 1 2 (0.5) 1 1 1
Rifampicin .128 .128 .128 .128 .128
Polymyxin B 1 2 (0.5) 0.5 (2) 0.5 (2) 1
Streptomycin 0.5 1 (0.5) 0.5 0.5 0.5
SDS 128 64 (2) 64 (2) 32 (4) 128
Choleate 32 768 32 768 32 768 32 768 32 768
aThe numbers in parentheses indicate the differences (n-fold) between
wild-type 11168 and the mutant strains. JB301, CPS mutant; JB302,
LOS mutant; JB303, CPS and LOS double mutant; JB302C, JB302 carrying
pRY112::waaF.
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Figure 1. Effect of CPS and LOS mutation on surface hydrophobicity of
C. jejuni. The concentration of ammonium sulphate is inversely proportional
to hydrophobicity. Each bar represents the mean+SEM of three different
experiments. WT, C. jejuni 11168; JB301, CPS mutant (kpsS::aphA3);
JB302, LOS mutant (waaF::tetO); JB303, CPS and LOS double mutant;
JB302C, JB302 harbouring pRY112::waaF.
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of natural transformation by 4- and 25-fold, respectively, and the
double mutation of both LOS and CPS significantly increased
the transformation frequency by 97-fold (Figure 2a). The results
were reproducible in four independent experiments. The differ-
ence between the wild-type and each mutant was statistically
significant (P,0.001). Since a greater change in transformation
was observed with the LOS mutant than with the CPS mutant,
we complemented the LOS mutant using a wild-type waaF
carried on a shuttle plasmid. In trans complementation
decreased the transformation frequency to a near wild-type
level (Figure 2b). The differences between the wild-type and
the waaF-complemented strain were statistically insignificant
(P.0.1).
CPS and LOS affected DNA binding and uptake
DNA binding and uptake assays were performed to determine
whether the LOS and CPS mutations affect DNA binding and
uptake in Campylobacter. The results demonstrated that DNA
binding and uptake increased 2- and 4-fold, respectively, in the
mutants (Figure 3). Despite variations observed between exper-
iments in the measured radioactivity levels, the fold differences
between the wild-type and the mutant strains remained consist-
ent. The fold changes in DNA uptake were statistically signifi-
cant in all of the mutants (P,0.01). The increase in DNA
binding was statistically significant (P,0.05) in JB301, but was
marginally non-significant in JB302 and JB303 as determined
by Bonferroni corrected t-test despite the trend of increased
DNA binding (Figure 3). Although JB303 consistently showed a
higher transformation frequency than JB301 and JB302
(Figure 2a), it did not demonstrate greater DNA binding and
uptake rates than the single mutants (Figure 3).
Discussion
The role of surface polysaccharides in mediating antibiotic
resistance in C. jejuni was determined in this study. Although a
previous study reported that the LOS mutation sensitized
C. jejuni to fusidic acid, novobiocin and SDS,16 it was unknown
if CPS also contributes to antimicrobial resistance and if both
CPS and LOS are important for resisting clinically relevant anti-
biotics, such as fluoroquinolones and macrolides. In this study,
we showed that C. jejuni LOS plays a significant role in the pro-
tection against the action of erythromycin (Table 2), which is
hydrophobic and a key antibiotic clinically used to treat
Campylobacter infection. Compared with LOS, CPS had a
limited impact on antimicrobial resistance in C. jejuni (Table 2).
Instead, the CPS mutation in C. jejuni slightly decreased the sus-
ceptibility to some hydrophilic antibiotics, such as cefotaxime,
gentamicin, streptomycin and polymyxin B (Table 2).
Campylobacter resistance to erythromycin is associated with
mutations in 23S rRNA29 and the function of the multidrug
efflux pump CmeABC.18 In this study, we showed that trunca-
tion of LOS reduced Campylobacter resistance to erythromycin
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Figure 2. Effect of CPS and LOS mutation on natural transformation in C. jejuni. (a) Transformation frequencies in various mutant constructs. The result is
representative of four independent experiments with triplicate transformation reactions. The donor DNA contained a chloramphenicol resistance marker (cat).
Each bar represents the mean+SEM. WT, C. jejuni 11168; JB301, CPS mutant; JB302, LOS mutant; JB303, CPS and LOS double mutant.
(b) Complementation of the waaF mutant in natural transformation. JB302C is JB302 complemented with pRY112::waaF. The result is representative of three
independent experiments with triplicate transformation. Since the complementing plasmid itself carried a cat gene, the genomic DNA containing the
kanamycin resistance marker (aphA3) was used as the donor DNA. Each bar represents the mean+SEM.
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Figure 3. Effect of CPS and LOS mutation on DNA binding and uptake in
C. jejuni. The result is representative of three independent experiments. Each
bar represents the mean+SEM of three samples in one experiment. In the
repeated experiments, similar patterns of results were obtained (see the
Results section). The statistically significant difference between each mutant
and the wild-type strain is indicated by one asterisk (P,0.01) or two
asterisks (P,0.05). WT, C. jejuni 11168; JB301, CPS mutant; JB302,
LOS mutant; JB303, CPS and LOS double mutant.
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(Table 2). In other bacteria, it has been shown that loss of LPS
renders bacterial cells more permeable to hydrophobic agents
and consequently increases the sensitivity to hydrophobic anti-
biotics.1,4 Many Gram-negative bacteria such as E. coli and
Salmonella Typhimurium are intrinsically resistant to hydro-
phobic antimicrobial agents including erythromycin, and this
intrinsic resistance to erythromycin is ascribed to the exclusion
of hydrophobic antibiotics by the hydrophilic LPS.1,4 Since
C. jejuni only has LOS and does not have the full-length LPS, it
is much more susceptible to macrolides than E. coli and
Salmonella, explaining why macrolide antibiotics are suitable
for treating Campylobacter infections. In this study, we showed
that truncation of LOS further increased the susceptibility of
Campylobacter to erythromycin. Unlike hydrophilic antibiotics,
which traverse the outer membrane through water-filled channels
such as porins, hydrophobic macrolides diffuse through the
outer membrane via hydrophobic interaction.1,4 Based on the
fact that truncation of LOS significantly increased the hydropho-
bicity of Campylobacter (Figure 1), we speculate that the LOS
mutant was more permeable to erythromycin and thus more sus-
ceptible to the antibiotic than the wild-type strain.
Although both CPS and LOS affected the hydrophobicity of
C. jejuni (Figure 1), loss of CPS alone did not alter the bacterial
susceptibility to erythromycin (Table 2). This was probably due
to the possibility that LOS alone provides a sufficient barrier for
diffusion of macrolides across the outer membrane in
Campylobacter. WaaF is responsible for the addition of the
second heptose to the inner-core region of C. jejuni LOS, and its
mutation results in the formation of truncated LOS16,28
(Figure S1a). The LOS mutant containing the waaF mutation
showed a slight (2-fold) reduction in the MIC level of poly-
myxin B (Table 2). The increased sensitivity to SDS by the LOS
mutation was reported in a previous study16 and was confirmed
by our result (Table 2). However, the CPS and LOS mutants did
not show any changes in the susceptibility to choleate (Table 2),
indicating that the surface polysaccharides do not contribute
significantly to bile resistance.
Natural transformation is an important mechanism of hori-
zontal gene transfer and significantly mediates the spread of
antimicrobial resistance determinants in Campylobacter.12,31
Natural transformation requires many protein components and is
distinct from other artificial DNA transformations such as heat-
shock transformation and electroporation.32 Although the role of
LPS in conjugation and heat-shock transformation was reported
in naturally non-competent Salmonella Typhimurium,33,34 to our
knowledge this is the first report documenting the role of bac-
terial polysaccharides in natural transformation. In this study, we
showed that bacterial surface polysaccharides, especially LOS,
reduced the transformation frequencies in C. jejuni (Figure 2).
How the surface polysaccharides reduce natural transformation
in Campylobacter may be explained by two possibilities. First,
both DNA and the surface polysaccharides are negatively
charged and electrostatic repulsion between them may restrict
the contact of transforming DNA with the bacterial surface.
Second, CPS and LOS may act as physical barriers, sterically
and/or structurally hindering the binding of DNA to receptor
protein(s) located in the outer membrane. In either case, the
surface polysaccharide would reduce the rate of DNA uptake by
bacterial cells. Indeed, our results showed that loss of CPS and
LOS significantly increased DNA uptake into Campylobacter
cells (Figure 3), supporting the notion that surface
polysaccharides limit the interaction of transforming DNA with
specialized DNA binding and uptake apparatuses in the mem-
brane. JB303 (double mutant) showed a higher transformation
frequency than the single mutants (Figure 2a), but the measured
rate of DNA binding and uptake in JB303 was not higher than
those of the single mutants (Figure 3). The reason for this dis-
crepancy is unknown, but it might be explained by the low sen-
sitivity of the DNA uptake assay, which did not allow the
differentiation of DNA uptake rates among the mutants.
It was previously reported that the galE mutation in C. jejuni
strain 81116 resulted in the formation of truncated LOS and a
20-fold decrease in the natural transformation frequency,
suggesting that the LOS mutation reduced the natural transform-
ation frequency of this C. jejuni strain,35 which is in contrast to
the findings obtained in this study. However, GalE is an epimer-
ase with dual functions that converts glucose to galactose and
N-acetylglucosamine to N-acetylgalactosamine36 and is required
for three important pathways including CPS biosynthesis, LOS
production and N-linked protein glycosylation.13,37 Thus,
mutation of galE would result in pleiotropic changes and affect
the production of LOS and CPS35,36 as well as the N-linked
protein glycosylation.36 Since the N-linked protein glycosylation
plays a significant role in the natural transformation of
C. jejuni,38 it is likely that the reduced natural transformation
frequency in the C. jejuni galE mutant was not caused by the
truncation of LOS, but was due to an altered N-linked protein
glycosylation system.
In conclusion, we demonstrated in this study that loss of
LOS, but not CPS, significantly reduced Campylobacter resist-
ance to erythromycin, an important antibiotic for treating human
campylobacteriosis. It was also shown that loss of LOS and CPS
increased the frequency of natural transformation in C. jejuni
strain NCTC 11168, which may ultimately affect the horizontal
transfer of antibiotic resistance determinants. Given that both
CPS and LOS are highly diverse and phase variable in
Campylobacter,13,30 the results from this study suggest that the
variable production of CPS and LOS in different Campylobacter
strains may contribute to their intrinsic differences in anti-
microbial susceptibility and natural transformation of antibiotic
resistance genes.
Acknowledgements
We would like to thank Jun Lin at the University of Tennessee
for providing some of the erythromycin-resistant isolates used in
this study.
Funding
This study was supported by the National Institutes of Health
grant R01DK063008 and the National Research Initiative com-
petitive grant 2007-35201-18278 from the USDA Cooperative
State Research, Education, and Extension Service.
Transparency declarations
None to declare.
Antibiotic resistance and transformation in Campylobacter
467
Downloaded from https://academic.oup.com/jac/article-abstract/63/3/462/693080/Roles-of-lipooligosaccharide-and-capsular
by Iowa State University user
on 22 September 2017
Supplementary data
Figure S1 is available as Supplementary data at JAC Online
(http://jac.oxfordjournals.org/).
References
1. Nikaido H, Vaara M. Molecular basis of bacterial outer mem-
brane permeability. Microbiol Rev 1985; 49: 1–32.
2. Whitfield C. Biosynthesis and assembly of capsular polysacchar-
ides in Escherichia coli. Annu Rev Biochem 2006; 75: 39–68.
3. Hancock RE. The bacterial outer membrane as a drug barrier.
Trends Microbiol 1997; 5: 37–42.
4. Vaara M. Agents that increase the permeability of the outer
membrane. Microbiol Rev 1992; 56: 395–411.
5. Mead PS, Slutsker L, Dietz V et al. Food-related illness and
death in the United States. Emerg Infect Dis 1999; 5: 607–25.
6. Friedman CR, Neimann J, Wegener HC et al. Epidemiology of
Campylobacter jejuni infections in the United States and other industri-
alized nations. In: Nachamkin I, Blaser MJ, eds. Campylobacter.
Washington, DC: ASM Press, 2000; 121–38.
7. Allos BM. Campylobacter jejuni infections: update on emerging
issues and trends. Clin Infect Dis 2001; 32: 1201–6.
8. Engberg J, Aarestrup FM, Taylor DE et al. Quinolone and
macrolide resistance in Campylobacter jejuni and C. coli: resistance
mechanisms and trends in human isolates. Emerg Infect Dis 2001; 7:
24–34.
9. Putman M, van Veen HW, Konings WN. Molecular properties of
bacterial multidrug transporters. Microbiol Mol Biol Rev 2000; 64:
672–93.
10. Zhang Q, Plummer PJ. Mechanisms of antibiotic resistance in
Campylobacter jejuni. In: Nachamkin I, Szymanski CM, Blaser MJ, ed.
Campylobacter. Washington, DC: ASM Press, 2008; 263–76.
11. Wang Y, Taylor DE. Natural transformation in Campylobacter
species. J Bacteriol 1990; 172: 949–55.
12. Jeon B, Muraoka W, Sahin O et al. Role of Cj1211 in natural
transformation and transfer of antibiotic resistance determinants in
Campylobacter jejuni. Antimicrob Agents Chemother 2008; 52:
2699–708.
13. Karlyshev AV, Ketley JM, Wren BW. The Campylobacter jejuni
glycome. FEMS Microbiol Rev 2005; 29: 377–90.
14. Fouts DE, Mongodin EF, Mandrell RE et al. Major structural
differences and novel potential virulence mechanisms from the
genomes of multiple Campylobacter species. PLoS Biol 2005; 3: e15.
15. Parkhill J, Wren BW, Mungall K et al. The genome sequence of
the food-borne pathogen Campylobacter jejuni reveals hypervariable
sequences. Nature 2000; 403: 665–8.
16. Kanipes MI, Holder LC, Corcoran AT et al. A deep-rough mutant
of Campylobacter jejuni 81-176 is noninvasive for intestinal epithelial
cells. Infect Immun 2004; 72: 2452–5.
17. Perera VN, Nachamkin I, Ung H et al. Molecular mimicry in
Campylobacter jejuni: role of the lipo-oligosaccharide core oligosac-
charide in inducing anti-ganglioside antibodies. FEMS Immunol Med
Microbiol 2007; 50: 27–36.
18. Lin J, Yan M, Sahin O et al. Effect of macrolide usage on emer-
gence of erythromycin-resistant Campylobacter isolates in chickens.
Antimicrob Agents Chemother 2007; 51: 1678–86.
19. Wo¨sten MM, Boeve M, Koot MG et al. Identification of
Campylobacter jejuni promoter sequences. J Bacteriol 1998; 180:
594–9.
20. Bacon DJ, Alm RA, Burr DH et al. Involvement of a plasmid in
virulence of Campylobacter jejuni 81-176. Infect Immun 2000; 68:
4384–90.
21. Karlyshev AV, Wren BW. Detection and initial characterization of
novel capsular polysaccharide among diverse Campylobacter jejuni
strains using alcian blue dye. J Clin Microbiol 2001; 39: 279–84.
22. Miller WG, Bates AH, Horn ST et al. Detection on surfaces and in
Caco-2 cells of Campylobacter jejuni cells transformed with new gfp, yfp,
and cfp marker plasmids. Appl Environ Microbiol 2000; 66: 5426–36.
23. Lin J, Michel LO, Zhang Q. CmeABC functions as a multidrug
efflux system in Campylobacter jejuni. Antimicrob Agents Chemother
2002; 46: 2124–31.
24. Misawa N, Blaser MJ. Detection and characterization of autoag-
glutination activity by Campylobacter jejuni. Infect Immun 2000; 68:
6168–75.
25. D’Agostino RB, Belanger A, D’Agostino RB Jr. A suggestion for
using powerful and informative tests of normality. Am Stat 1990; 44:
316–21.
26. Levene H. Robust tests for equality of variances. In: Olkin I, ed.
Contributions to Probability and Statistics: Essays in Honor of Harold
Hotelling. Stanford, CA: Stanford University Press, 1960; 278–92.
27. Karlyshev AV, Linton D, Gregson NA et al. Genetic and bio-
chemical evidence of a Campylobacter jejuni capsular polysaccharide
that accounts for Penner serotype specificity. Mol Microbiol 2000; 35:
529–41.
28. Oldfield NJ, Moran AP, Millar LA et al. Characterization of the
Campylobacter jejuni heptosyltransferase II gene, waaF, provides
genetic evidence that extracellular polysaccharide is lipid A core inde-
pendent. J Bacteriol 2002; 184: 2100–7.
29. Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni
and Campylobacter coli. J Antimicrob Chemother 2006; 58: 243–55.
30. Bacon DJ, Szymanski CM, Burr DH et al. A phase-variable
capsule is involved in virulence of Campylobacter jejuni 81-176. Mol
Microbiol 2001; 40: 769–77.
31. Young KT, Davis LM, Dirita VJ. Campylobacter jejuni: molecular
biology and pathogenesis. Nat Rev Microbiol 2007; 5: 665–79.
32. Dubnau D. DNA uptake in bacteria. Annu Rev Microbiol 1999;
53: 217–44.
33. Sanderson KE, Janzer J, Head J. Influence of lipopolysacchar-
ide and protein in the cell envelope on recipient capacity in conjugation
of Salmonella typhimurium. J Bacteriol 1981; 148: 283–93.
34. MacLachlan PR, Sanderson KE. Transformation of Salmonella
typhimurium with plasmid DNA: differences between rough and smooth
strains. J Bacteriol 1985; 161: 442–5.
35. Fry BN, Feng S, Chen YY et al. The galE gene of
Campylobacter jejuni is involved in lipopolysaccharide synthesis and
virulence. Infect Immun 2000; 68: 2594–601.
36. Bernatchez S, Szymanski CM, Ishiyama N et al. A single bifunc-
tional UDP-GlcNAc/Glc 4-epimerase supports the synthesis of three
cell surface glycoconjugates in Campylobacter jejuni. J Biol Chem
2005; 280: 4792–802.
37. Szymanski CM, Wren BW. Protein glycosylation in bacterial
mucosal pathogens. Nat Rev Microbiol 2005; 3: 225–37.
38. Larsen JC, Szymanski C, Guerry P. N-linked protein glycosyla-
tion is required for full competence in Campylobacter jejuni 81-176.
J Bacteriol 2004; 186: 6508–14.
Jeon et al.
468
Downloaded from https://academic.oup.com/jac/article-abstract/63/3/462/693080/Roles-of-lipooligosaccharide-and-capsular
by Iowa State University user
on 22 September 2017
